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INTERICTAL HYPOSEXUALITY IN MALE
PATIENTS WITH EPILEPSY
Diosely C. Silveira1, Elizabeth A. P. de Souza2, José F. Carvalho3, Carlos A. M. Guerreiro4
ABSTRACT - The purpose of this study was to compare the serum levels of androgens between hyposexual and
non-hyposexual patients with epilepsy. Adult male patients with epilepsy were investigated. Serum levels of
testosterone (T) and free-T, estradiol, and sex hormone binding globulin (SHBG) were measured and the free
androgen index (FAI) was calculated. While there were no differences between hyposexual and non-hyposexual
patients in the serum levels of T, free-T, and estradiol, or to the FAI, the serum levels of SHBG were significantly
higher in hyposexual patients than in non-hyposexual patients. Thus, the effects of increased SHBG upon
serum levels of testosterone biologically active in patients with epilepsy and hyposexuality were not detected
by the methods used in this study. Four (44%) of nine hyposexual patients who were re-evaluated after two
years follow-up improved sexual performance. Thus, clinical treatment that results in good seizure control
may improve sexual performance in some patients with epilepsy.
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Hipossexualidade interictal em homens com epilepsia
RESUMO - O objetivo deste estudo foi comparar os níveis séricos de andrógenos e estradiol entre pacientes do
sexo masculino com e sem hipossexualidade. Níveis séricos de testosterona e testosterona porção livre, estradiol
e globulina ligadora de hormônio sexual (SHBG) foram dosados e calculado o índice de andrógeno livre (FAI).
Não houve diferença significante de testosterona, porção livre de testosterona, estradiol e de FAI nos pacientes
com e sem hipossexualidade. Os níveis de SHBG foram significantemente maiores nos pacientes hipossexuais
quando comparados com os pacientes sem hipossexualidade. Deste modo, os efeitos da SHBG aumentada
nos níveis séricos de testosterona biologicamente ativa, em pacientes com epilepsia e hipossexualidade, não
foram detectados pelo método usado neste estudo. Quatro (44%) pacientes, reavaliados após dois anos de
seguimento, tiveram melhora significativa do desempenho sexual. Portanto, o tratamento medicamentoso,
com melhor controle das crises epilépticas, pode melhorar o comportamento sexual de alguns pacientes com
epilepsia.
PALAVRAS-CHAVE: epilepsia, disfunção sexual, testosterona, andrógenos.
1Research fellow, Neurology Department, Childrens Hospital and Harvard Medical School, Boston, MA, USA; 2PhD. Professor Assistente,
Departamento de Neurologia da Faculdade de Ciências Médicas (FCM), Universidade Estadual de Campinas (UNICAMP); 3PhD. Professor
Assistente, Departamento de Matemática e Estatística, FCM/UNICAMP; 4MD, PhD. Professor Assistente, Departamento de Neurologia,
FCM/UNICAMP.
Received 16 August 2000, received in final form 3 October 2000. Accepted 3 October 2000.
Diosely C. Silveira, MD, PhD - Childrens Hospital - 300 Longwood Avenue, Enders # 320 - Boston, MA 02115 - USA. Fax: 1 617 734 1646.
E-mail: silveira@A1.tch.harvard.edu
Hyposexuality is one of the most frequent (28%-
67%) interictal abnormalities observed in patients
with epilepsy1-5. Several factors may disrupt normal
sexual function in patients with epilepsy, including
psychological influences, hormonal disorders, antie-
pileptic drugs (AEDs), and the disease itself6.
Androgens are important for the maintenance of
libido and sexual potency7,8. Decreased serum levels
of free-testosterone (free-T) have been associated
with diminished libido and erectile dysfunction9. The
majority (98%) of plasma testosterone (T) is linked
to proteins, 43% to 45% to albumin, 53% to 55% to
sex hormone binding globulin (SHBG), and 2% cir-
culate under free form10. The free androgen index
(FAI) may indirectly estimate the serum levels of T
bound to albumin11, which is also considered to be
biologically active.
Whether AEDs, the disease itself, or both factors
modulate sexual dysfunction in patients with epi-
lepsy remain unclear. While some studies implicate
low serum levels of free-T as the cause of hypose-
xuality12-16, other studies17,18 found normal serum lev-
els of free-T, increased SHBG, and reduced FAI in
patients with epilepsy and hyposexuality. The ma-
jority of studies investigated sexual function in pa-
tients with refractory epilepsy, particularly those can-
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didates to temporal lobe surgical resection. The ef-
fects of less severe seizures on sexual function are
still unclear.
The purpose of this study was to compare the se-
rum levels of androgens and estradiol between male
hyposexual and non-hyposexual outpatients with epi-
lepsy. Patients were inquired about sexual function at
the beginning of this study and after two years of
follow-up. Clinical variables, including the age of sei-
zure onset, seizure type and frequency, and serum lev-
els of androgens and estradiol were compared among
hyposexual and non-hyposexual patients.
METHOD
Subjects
The Committee of Ethics in Medicine of the General
Hospital, Campinas University (São Paulo, Brazil) approved
this study. Written informed consent was obtained from
both patients and healthy individuals.
Forty-two outpatients from the Epilepsy Unit, Neurol-
ogy Department, Campinas University, were included dur-
ing the period of six months. Two patients refused to par-
ticipate in this study and one patient, who had severe
difficulties in relationship with his wife, was excluded.
Thus, 39 patients were investigated. Thirty-nine healthy
individuals, who used to come with patients to the same
hospital, were interviewed about sexual function but not
submitted to hormonal dosages. Both patients and con-
trols were selected because of gender (male patients), age
(from 20 to 45 years), and marital state (married). In all
cases, other associated pathologies, as well as heavy alco-
hol consumption had been ruled out.
Interviews
Interviews about sexual function were carried out
blinded by a second independent investigator. Patients
were interviewed at the beginning of this study and after
two years of follow-up. The classification of sexual dys-
function was based on Diagnostic and Statistical Manual
of Mental Disorders19. During the interviews, we followed
a routine of anamnesis of sexual function as follows: 1)
Libido, including self-report of sexual desire and frequency
of search of sexual intercourse; 2) Sexual potency, includ-
ing frequency of sexual intercourse that culminate in or-
gasm, frequency of masturbation that culminate in or-
gasm, capacity to obtain and/or maintain penile erections,
approximate duration of penile erections, and frequency
of complete erections; 3) Self-report of sexual satisfac-
tion, from completely satisfied to completely unsatisfied
with their sexual experiences and performance. Some of
the questions about sexual activity were based on Thornes
Sexual Inventory20, including the frequency of search for
sexual intercourse and the degree of satisfaction in sexual
experiences.
Libido was considered decreased or absent when the
subject reported diminishment or absence of sexual de-
sire and had frequency of search for sexual intercourse at
least less than once a month. Potency and sexual pleasure
were considered reduced or absent when the frequency
of sexual intercourse that culminate in orgasm were at
least less than once a month, and/or when there was a
failure persistent or recurrent, partial or complete in ob-
tain and/or maintain penile erections until the end of sexual
activity. Sexual satisfaction was investigated in all cases.
Those who were satisfied were not considered hyposexual,
even with low frequency of sexual activity or decreased
sexual desire.
Only the sexual dysfunction that occurred persistently
or recurrently during a period longer than six months was
considered for analysis. We did not consider temporary or
occasional complains about sexual function. In addition,
premature ejaculation, which is commonly seen in the
general population21, was not considered hyposexuality.
Those who presented decreased or absent sexual potency
and/or libido lasting a period greater than six months and
were completely unsatisfied with their sexual experiences
were considered hyposexual.
Seizure frequency
The frequency of seizures was divided as follows: a)
Very frequent: seizures occurring several times a day or at
intervals shorter than seven days; Frequent: seizures at
intervals longer than seven days but shorter than 30 days;
Occasional: seizures at intervals longer than 30 days but
shorter than one year; Rare: seizures at intervals longer
than one year.
Hormonal dosages
Blood samples were taken between 9am to 10 am af-
ter 30 minutes of rest. Patients were seizure free for at
least 48 hours before the blood drawn. The samples were
left to coagulate at room temperature, centrifuged, and
stored in a freezer at -20°C for further hormonal dosages.
Serum levels of T and free-T were determined by radio-
immunoassay, serum levels of estradiol and SHBG were
determined by immunoradiometric method. The sensitiv-
ity of the T-assay was 0.22 ng/ml; the intraassay coeffi-
cient of variation was 2.63%; the interassay coefficient of
variation was 1.2%. The sensitivity of the free-T-assay was
0.15 pg/ml; the intraassay coefficient of variation was
3.15%; the interassay coefficient of variation was 4.2%.
The sensitivity of the SHBG-assay was 0.1 nmol/ml; the
intraassay coefficient of variation was 3.58%; the interassay
coefficient of variation was 5.1%. The sensitivity of the
estradiol-assay was 0.9 pg/ml; the intraassay coefficient of
variation was 1.55%; the interassay coefficient of varia-
tion was 5.56%. FAI was calculated by multiplying the
serum levels of T (nmol/L) by 100 and dividing the serum
levels of SHBG (nmol/L) as follows: FAI = TTx100/SHBG.
Data analysis
Thirty-nine patients were selected to participate in this
study. For each patient a non-paired control (n = 39) was
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selected for comparisons regarding the presence of sexual
dysfunction. Subsequently, two groups of patients were
compared as follows: a) hyposexual group: patients with
epilepsy and sexual dysfunction, b) non-hyposexual group:
patients with epilepsy and normal sexual function. It was
observed clinical variables related to epilepsy, AEDs, hor-
monal dosage, and variables related to sexual perfor-
mance. The Grizzle, Starmer, Koch22 model was used for
comparisons. It was used IBM-PC computer under Win-
dows, with statistical software SAS (SAS Institute, Cary,
N.C.). For analysis of sexual interviews, a table of frequency
of the conditions before and after was used. Pearsons Q-
square was used for tests of independence.
RESULTS
First interview about sexual performance in pa-
tients with epilepsy and control group:
Eleven (28.2%) patients were considered
hyposexual. Ten patients had decreased or absent
libido and sexual potency and one had decreased
sexual potency and unaltered libido. All patients were
completely unsatisfied with their sexual experiences
and performance. The hyposexuality began after
epileptic seizures in all patients. The age of onset of
hyposexuality ranged from 26 to 40 years (mean:
32.2). One (2.6%) individual of the control group
was considered hyposexual. He had decreased libido
and sexual potency. This individual was completely
unsatisfied with his sexual experiences and perfor-
mance. Hyposexuality was more frequently
(p=0.002; x2=9.848) observed in patients with epi-
lepsy than in the control group.
Clinical data
The mean ages of patients with or without sexual
dysfunction were identical. Hyposexual patients were
between 28 and 45 years old (mean: 35.4) and non-
hyposexual patients were between 24 and 44 years
old (mean: 35.4). Similarly, no significant differences
in education were found between groups. The ma-
jority of patients from both groups had not com-
pleted secondary school. All hyposexual (100%) pa-
tients and 21 (75%) non-hyposexual patients had
partial seizures with or without secondary genera-
lization, and seven (25%) non-hyposexual patients
had generalized tonic-clonic seizures. Nine (81.8%)
of 11 hyposexual patients and 12 (42.8%) of 28 non-
hyposexual patients had temporal lobe epilepsy (TLE;
Table 1). TLE was significantly (p = 0.028; x2 = 4.824)
more commonly observed among hyposexual than
non-hyposexual patients.
No significant differences were found between
groups in relation to the seizure frequency. The fre-
quency of seizures in hyposexual patients was as
follows: Four (36.4%) patients had very frequent
seizures, one (9.1%) patient had frequent seizures,
three (27.3%) patients had occasional seizures, and
three (27.3%) patients had rare seizures. The fre-
quency of seizures in non-hyposexual patients was
as follows: Seven (25%) patients had very frequent
seizures, five (17.8%) patients had frequent seizures,
six (21.4%) patients had occasional seizures, and 10
(35.7%) patients had rare seizures. In addition, no
evidences of significant differences were found be-
tween groups in relation to the age of seizure on-
set, and type or serum levels of AEDs.
Brain computed tomography (CT) was normal in
29 (74.3%) patients and abnormal in 10 (25.7%)
patients. Seven patients with abnormal CT scan ful-
filled-up the criteria of possibility for the diagnosis
of calcified form of intracerebral neurocysticercosis
(23), with multiple or single nodular calcifications.
The other three patients had sequelae of head
trauma as follows: two hyposexual patients had left
frontal and right temporal areas of hypodensity on
CT scan, respectively, and one non-hyposexual pa-
tient had bilateral frontal areas of hypodensity on
CT scan. No significant differences were found be-
tween hyposexual and non-hyposexual patients in
relation to brain lesions detected by CT scan. Mag-
netic resonance imaging (MRI) was not performed
Table 1. Mean serum levels of androgens, estradiol, and SHBG, and the mean of free androgen index.
Hormone Hyposexual Non-Hyposexual
Total testosterone (T) 7.02 ± 1.17o 6.56 ± 0.45
Free testosterone (free T) 15.44 ± 1.25 14.94 ± 1.11
SHBG 73.97 ± 15.41* 42.78 ± 3.91
Estradiol 16.63 ± 3.68 11.69 ± 1.68
Free androgen index 19.74 ± 2.89 22.8 ± 1.58
o Mean ± SEM; *p<0.05
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in all patients in this study and consequently not
considered for analysis.
Serum levels of T, FT, SHBG, and FAI (Table 1)
There was no evidence of significant differences
between hyposexual and non-hyposexual patients
in relation to serum levels of T, free-T, or estradiol.
Similarly, we did not find evidences of significant
differences in the FAI between hyposexual and non-
hyposexual patients. However, the serum levels of
SHBH were significantly (p<0.05) higher between
hyposexual than non-hyposexual patients.
Second interview about sexual performance
in patients with epilepsy after two-years
follow-up period
Thirty-six (92.3%) patients could be re-evaluated
at this time. Among the remaining three patients,
two did not return to the routine visits and one de-
veloped systemic arterial hypertension and was ex-
cluded. Among those patients previously considered
hyposexual, nine were re-evaluated. Four (44.4%)
had improvement in their sexual performance and
were considered non-hyposexual, whereas five
(55.6%) continued hyposexual. Among those patients
previously considered non-hyposexual, 27 (96.4%)
were re-evaluated and one (3.7%) developed
hyposexuality. Thus, during the second interview, six
(16.7%) patients were considered hyposexual.
All four patients that improved sexual performance
during the follow-up period were taking AEDs and
had concomitant improvement in seizure frequency
as follows: two had no seizures and two had one
seizure during the year that preceded the second
interview. Among those patients that continued or
developed hyposexuality, three had very frequent
seizures that were refractory to AEDs treatment and
three had occasional seizures. Two of these
hyposexual patients with low seizure frequency had
sequelae of head trauma in the left frontal and right
temporal lobes, respectively.
The analysis of hyposexuality among the first and
second interviews about sexual performance was
done using table of frequency of conditions before
and after. It was used Pearsons Q-square for test of
independence. The result (p = 0.000; x2 = 13.067)
shows evidence of significant differences among the
first and second evaluations. Although limited by the
small sample of hyposexual patients, the results ob-
tained in this study may indicate the benefits of clini-
cal treatment and seizure control on sexual perfor-
mance in patients with epilepsy.
DISCUSSION
Hyposexuality was more frequently observed
among patients with epilepsy than in healthy indi-
viduals. We observed hyposexuality in almost 30% of
men with epilepsy. The majority of hyposexual patients
showed global diminishment of libido and potency.
We compared sexual activity before and after two
years of follow-up in more than 90% of our patients.
The analysis of hyposexuality between the first and
second interviews about sexual performance showed
evidence of improvement in sexual performance
between the first and second evaluations.
Although we did not find any differences between
seizure frequency and impairment or improvement
of sexual function, our results suggest that some
patients with good outcome regarding seizure con-
trol improve sexual activity. In this study, 44% of
patients that were considered hyposexual improved
sexual performance during the two-year follow-up
period. In contrast, five patients that persisted
hyposexual or developed hyposexuality during the
two-year follow-up had either seizures refractory to
treatment with AEDs (n=3) or sequelae of temporal
(n=1) or frontal (n=1) head trauma. In the former
patients, the cause of sexual dysfunction is prob-
ably the structural brain lesion in the temporal and
frontal lobes, respectively. Previous studies demon-
strated that patients with refractory epilepsy im-
proved sexual performance after temporal lobec-
tomy2,3,5,24. Based on the fact that both clinical and
surgical treatment for epilepsy that result in better
seizure control may influence sexual performance,
it is possible that the disease itself contributes to
hyposexuality.
In agreement with previous studies1-5, hypo-
sexuality began after epilepsy in all patients in this
study. Temporal lobe seizures were more commonly
observed among hyposexual than non-hyposexual
patients. Nine (81.8%) of 11 hyposexual patients and
12 (42.8%) of 28 non-hyposexual patients had lim-
bic seizures. Limbic seizures have been associated
with hyposexuality in humans1-5 and animals25. In
male cats, hyposexuality was observed after amygda-
loid seizures but not motor cortex seizures25. The
temporal lobes have long been involved in the modu-
lation of sexual behavior26. In 1939, Kluver and Bucy26
described hypersexuality, excessive oral tendency, loss
of expected fear and anger, visual agnosia, and di-
etary changes in monkeys submitted to bilateral
lobectomy. In humans, post-ictal Kuver Bucy syn-
drome was observed after temporal lobectomy27.
Thus, ablation of the temporal lobes exacerbates
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sexual activity while human temporal lobe epilepsy
usually inhibits sexual function. However, the mecha-
nisms underlying the association between limbic
epilepsy and sexual dysfunction remain unclear.
While serum levels of T and free-T were not sig-
nificantly different among hyposexual and non-
hyposexual patients, serum levels of SHBG were in-
creased in the hyposexual group. Previous stud-
ies12,15,17,18,28-30 showed high serum levels of SHBG in
patients treated with AEDs. Increased SHBG would
expect to produce sexual dysfunction by decreasing
serum levels of free-T and/or albumin-bound test-
osterone, which was indirectly estimated by FAI in
this study. However, the effects of increased serum
levels of SHBG upon free-T and FAI were not signifi-
cantly different between groups. Although FAI has
been used in several studies, it is controversial
whether FAI is an appropriate measurement for
males31,32. Based on the facts that increased SHBG
did not elicit marked differences between hyposexual
and non-hyposexual patients in relation to the se-
rum levels of free-T measured by RIA and that FAI
may not be reliable for male individuals31,32, further
study with more accurate measurements of the
bioavailable androgens are necessary to elucidate
whether increased SHBG contribute to the sexual
dysfunction frequently observed in patients with
epilepsy.
The serum levels of estradiol did not differ be-
tween hyposexual and non-hyposexual patients in
this study. The results about serum levels of estra-
diol in patients with epilepsy and sexual dysfunc-
tion are controversial. While Murialdo et al.33 found
increased serum levels of estradiol, Duncan et al.34
did not find altered levels of estradiol in patients
with sexual dysfunction and epilepsy.
Our goal was not to report the complete evalua-
tion for sexual dysfunction in patients with epilepsy.
However, all patients in this study were submitted
to psychological and urological evaluations. Previ-
ously, Souza et al.35 reported a significant associa-
tion between sexual dysfunction, anxiety, and de-
pression in male and female patients with epilepsy.
Depressive disorders, which are frequently observed
in patients with epilepsy36, may cause sexual dys-
function. In addition, previous study37 found vascu-
lar impotence in two of 11 male patients with epi-
lepsy and sexual dysfunction. Thus, it is important
to empathize that the evaluation of patients with
epilepsy and sexual dysfunction requires a multidis-
ciplinary approach.
CONCLUSION
The results obtained in this study may indicate
the benefits of clinical treatment and seizure control
on sexual performance in some patients with
epilepsy. The serum levels of SHBG were higher in
hyposexual than in non-hyposexual patients with
epilepsy. However, the effects of increased SHBG on
bioavailable androgens, including free-T and
albumin-bound T were not detected by the methods
used in this study.
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